InnoCare Pharma 9M Operating Rev RMB2.10 Billion
Oct 26 (Reuters) - InnoCare Pharma -
- 9m Net profit attributable rmb655.7 mln.
- InnoCare Pharma - 9m operating rev rmb2.10 bln
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement